Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hermann Nehoda

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Obesity Research|July 10, 2002
Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptinMarkus Laimer, Christoph F Ebenbichler, Susanne Kaser, et al.
Obesity Surgery|January 24, 2004
DaVinci robotic-assisted laparoscopic bariatric surgery: is it justified in a routine setting?Gilbert Mühlmann, Alexander Klaus, Werner Kirchmayr, et al.
Anticancer Research|December 27, 2011
Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II studyWolfgang Eisterer, Alexander DE Vries, Dorota Kendler, et al.
Cancers|January 25, 2025
Does Total Neoadjuvant Therapy Impact Surgical Precision in Total Mesorectal Excision? A Nationwide Survey of the Experiences of Expert SurgeonsTarkan Jäger, Matthias Zitt, Stefan Riss, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Obesity Research|July 10, 2002
Weight loss increases soluble leptin receptor levels and the soluble receptor bound fraction of leptinMarkus Laimer, Christoph F Ebenbichler, Susanne Kaser, et al.
Obesity Surgery|January 24, 2004
DaVinci robotic-assisted laparoscopic bariatric surgery: is it justified in a routine setting?Gilbert Mühlmann, Alexander Klaus, Werner Kirchmayr, et al.
Anticancer Research|December 27, 2011
Triple induction chemotherapy and chemoradiotherapy for locally advanced esophageal cancer. A phase II studyWolfgang Eisterer, Alexander DE Vries, Dorota Kendler, et al.
Cancers|January 25, 2025
Does Total Neoadjuvant Therapy Impact Surgical Precision in Total Mesorectal Excision? A Nationwide Survey of the Experiences of Expert SurgeonsTarkan Jäger, Matthias Zitt, Stefan Riss, et al.
Pageof 3